Top Markets
Coin of the day
Genovate Biotechnology Co., Ltd. Genovate Biotechnology Co., Ltd.

Genovate Biotechnology Co., Ltd.

4130
Rang in Aktien #21465
Genovate Biotechnology Co., Ltd. is a Taiwanese enterprise dedicated to the... Genovate Biotechnology Co., Ltd. is a Taiwanese enterprise dedicated to the research, development, production, and commercialization of various products. These offerings primarily aim to prevent and treat illnesses resulting from viral and bacterial infections. The company's diverse portfolio extends to drugs, active pharmaceutical ingredients (APIs), intermediates, and specialized release agents, which are crucial for addressing a range of health issues including cardiovascular, esophageal, gastrointestinal, cancer, and autoimmune conditions. Complementing its pharmaceutical offerings, Genovate also manufactures controlled-release Western medicine formulations and cosmetic items. Established in 1982, the company's operations are headquartered in Hsinchu City, Taiwan.
Aktienkurs
$0.84903405
Zuletzt synchronisiert: 2026-07-27
Marktkapitalisierung
$106.63M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
38.69%
Land
TW
Handel Genovate Biotechnology Co., Ltd. (4130)

Kategorie

Kursverlauf für Genovate Biotechnology Co., Ltd. (4130)
Höchster Schlusskurs: $0.87 am 2026-07-01

Niedrigster Schlusskurs: $0.15 am 2005-06-01
Kursverlauf der Aktie von Genovate Biotechnology Co., Ltd. von 2005 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 6.42%
2025 24.97%
2024 -22.23%
2023 -16.60%
2022 21.62%
2021 -18.02%
2020 27.33%
2019 -1.89%
2018 -19.60%
2017 -4.24%
2016 -35.79%
2015 -15.23%
2014 65.59%
2013 -5.18%
2012 165.04%
2011 -14.13%
2010 45.34%
2009 70.44%
2008 -33.38%
2007 21.79%
2006 38.76%
2005 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH